Transcenta Holding Limited 創勝集團醫藥有限公司

Pay for financial year ended 2024-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chen, Helen Wei 陳瑋 INED 200 37 237
2 Qian, Xueming 錢雪明 Ch, CEO 569 499 15 63 894 2,040
3 Srinivasan, Kumar INED 200 20 220
4 Tang, Jiasong 唐稼松 INED 200 26 226
5 Weng, Xiaolu 翁曉路 FD 1,019 39 309 1,367
6 Xu, Li (1956) 徐莉 NED 68 569 53 527 1,217
7 Zhang, Zhihua (1982) 張志華 INED 200 26 226
8 Zhao, Jonathan Yining 趙奕寧 NED, Ch 12 555 567
Total 1,437 2,087 15 167 2,394 6,100

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,437 2,087 15 167 2,394 6,100 Report
2023-12-31 3,252 4,759 676 375 15,338 24,400 Report
2022-12-31 2,878 7,847 3,265 593 1,533 16,116 Report
2021-12-31 1,567 6,766 4,591 446 22,764 36,134 Report
Total 9,134 21,459 8,547 1,581 42,029 82,750

Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!


Webb-site Database - Powered By Linux Group

Back to top